Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

NCT06299371 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Adebrelimab
DRUG: paclitaxel for injection (albumin bound)
DRUG: Cisplatin or Carboplatin

Sponsor

Liaoning Cancer Hospital & Institute